Expert Insights

At the 2023 Great Debates & Updates in Hematologic Malignancies Meeting in New York, New York, Joseph Mikhael, MD, shared strategies for treating patients with multiple myeloma in early relapse.

At the SGO Annual Meeting on Women’s Cancer, Neil Horowitz, MD, discusses the efficacy of concurrent gemcitabine-cisplatin and intensity-modulated radiation therapy for locally advanced squamous cell carcinoma of the vulva.

At the 2023 Great Debates & Updates in Hematologic Malignancies conference in New York, New York, Melissa Alsina, MD, discussed possible future treatment options for patients with myeloma.

At the 2023 Great Debates & Updates in Hematologic Malignancies conference in New York, New York, Saad Z. Usmani, MD, MBA, FACP, discussed novel and cellular therapies used to treat relapsed/refractory multiple myeloma, including but not...

At the SGO Annual Meeting on Women’s Cancer, Jyoti Mayadev, MD, discusses best practices for treating patients with IB3 cervical cancer, focusing on the benefits of chemoradiation treatment.

Paolo Tarantino, MD, discusses advancements in genomic study and treatment efficacy for HER2-Low, HER2-Zero, and HER2-Positive breast cancers.

At the 2023 Great Debates & Updates in Hematologic Malignancies meeting in New York, New York, Andrew Artz, MD, participated in a debate about the benefits of hematopoietic stem cell transplantation among patients with AML with MRD after...

At the 2023 Great Debates & Updates in Hematologic Malignancies conference in New York, New York, Amer Zeidan, MBBS, MHS, discussed effective risk stratification among patients with myelodysplastic syndromes.

At the 2023 Great Debates & Updates in Hematologic Malignancies conference in New York, Richard Stone, MD, debated the role of measurable residual disease when considering hematopoietic stem cell transplantation for patients with acute...

At the 2023 Great Debates and Updates in Gastrointestinal Malignancies meeting, Cathy Eng, MD, offered her perspectives on the current and upcoming clinical trials for treatments of anal cancer.